|
Press Releases |
|
 |
|
Thursday, August 27, 2020 |
|
李氏大药厂公布2020中期业绩 |
结合研究主导和市场导向的中国药品制造公司 - 李氏大药厂控股有限公司 (「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2020年6月30日止(「回顾期内」)的中期业绩。 more info >> |
|
李氏大藥廠公佈2020中期業績 |
結合研究主導和市場導向的中國藥品製造公司 - 李氏大藥廠控股有限公司 (「李氏大藥廠」或「集團」;股票編號︰950),今天宣佈截至2020年6月30日止(「回顧期內」)的中期業績。 more info >> |
|
Lee's Pharm Announces 2020 Interim Results |
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group"; HKG: 950), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its interim results for the six months ended 30 June 2020 (the "period under review"). more info >> |
|
Thursday, November 28, 2019 |
|
李氏大药厂公布2019年第三季度业绩 |
结合研究主导和市场导向的中国药品制造公司- 李氏大药厂控股有限公司(「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2019年9月30日止九个月(「回顾期内」)之未经审核综合季度财务业绩。 more info >> |
|
李氏大藥廠公佈2019年第三季度業績 |
結合研究主導和市場導向的中國藥品製造公司 - 李氏大藥廠控股有限公司 (「李氏大藥廠」或「集團」;股票編號︰950),今天宣佈截至2019年9月30日止九個月(「回顧期內」)之未經審核綜合季度財務業績。 more info >> |
|
Lee's Pharm Announces 2019 Third Quarterly Results |
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its unaudited consolidated quarterly financial results for the nine months ended 30 September 2019 (the "period under review"). more info >> |
|
Thursday, October 31, 2019 |
|
COPFL宣布其全资附属公司ZKO自主研发的产品环孢霉素A眼科凝胶的II期临床研究已完满完成 |
China Ophthalmology Focus Limited(「COPFL」)今天宣布,其全资附属公司兆科(广州)眼科药物有限公司(「ZKO」) 自主研发的产品环孢霉素A眼科凝胶的II期临床研究已完满完成(clinicaltrials.gov登记号码:NCT03676335)。顶线数据显示,与市售环孢霉素A眼科乳剂相比,实验药物具有相似或更好的疗效趋势。 more info >> |
|
COPFL宣布其全資附屬公司ZKO自主研發的產品環孢霉素A眼科凝膠的II期臨床研究已完滿完成 |
China Ophthalmology Focus Limited(「COPFL」)今天宣布,其全資附屬公司兆科(廣州)眼科藥物有限公司(「ZKO」) 自主研發的產品環孢霉素A眼科凝膠的II期臨床研究已完滿完成(clinicaltrials.gov登記號碼:NCT03676335)。頂線數據顯示,與市售環孢霉素A眼科乳劑相比,實驗藥物具有相似或更好的療效趨勢。 more info >> |
|
COPFL announced that its wholly-owned subsidiary-ZKO, has successfully completed a Phase II trial of Cyclosporine A Ophthalmic Gel |
China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO"), has successfully completed a Phase II trial of Cyclosporine A (CsA) Ophthalmic Gel in China (clinicaltrials.gov registration No.:NCT03676335). Topline data show that the experimental drug has similar or a trend towards better efficacy than that of the marketed CsA Ophthalmic Emulsion. more info >> |
|
Thursday, March 28, 2019 |
|
李氏大药厂公布2018年全年业绩 |
结合研究主导和市场导向的中国药品制造公司-李氏大药厂控股有限公司(「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2018年12月31日止的全年业绩(「回顾年内」)。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
nybl Joins World AI Show & Awards as The Official Artificial Intelligence Partner
May 22, 2022 10:07 JST
|
|
|
云康集团 (02325.HK) 冀为中国医疗系统创新发展
May 21, 2022 16:11 HKT/SGT
|
|
|
雲康集團 (02325.HK) 冀為中國醫療系統創新發展
May 21, 2022 16:10 HKT/SGT
|
|
|
Straumann Malaysia, part of The Straumann Group, a Leading Implantology Company, Intends to Provide 3,000 Dental Implant Packages to the Ministry of Health Malaysia as part of MoU
May 21, 2022 09:20: JST
|
|
|
Straumann Malaysia, part of The Straumann Group, a Leading Implantology Company, Intends to Provide 3,000 Dental Implant Packages to the Ministry of Health Malaysia as part of MoU
May 21, 2022 08:20 HKT/SGT
|
|
|
MC and Morgenrot Enter into Capital and Business Alliance
May 20, 2022 20:19 JST
|
|
|
12th PropertyGuru Asia Property Awards (Singapore) search for the finest real estate as market sentiment improves
May 20, 2022 19:15 HKT/SGT
|
|
|
PhilSec 2022 Set to Discuss Strategies to Strengthen Philippines' Cybersecurity
May 20, 2022 16:35 HKT/SGT
|
|
|
金活醫藥即將銷售新冠抗原試劑盒!
May 20, 2022 16:30 HKT/SGT
|
|
|
TMT Offers Immersive Customer Experience with Latest Megastore in Pavilion Bukit Jalil
May 20, 2022 16:00 HKT/SGT
|
|
|
金活醫藥即將銷售新冠抗原試劑盒!
May 20, 2022 14:09 HKT/SGT
|
|
|
日産自動車・三菱自動車・NMKVが新型「軽EV」のオフライン式を実施
May 20, 2022 13:00: JST
|
|
|
ROOKIE Racing and TOM'S SPIRIT Announce Team Setups for Super Taikyu Series Fuji 24 Hours Race
May 20, 2022 13:42 JST
|
|
|
昭和電工、合成樹脂エマルジョンの販売価格改定を発表
May 20, 2022 11:30: JST
|
|
|
Sirnaomics将在2022年Pre-ASCO中国峰会介绍其RNAi疗法于肿瘤学领域临床研究结果与发展战略
May 20, 2022 11:12 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|